Current status of beta‐thalassemia and its treatment strategies

S Ali, S Mumtaz, HA Shakir, M Khan… - Molecular genetics & …, 2021 - Wiley Online Library
Background Thalassemia is an inherited hematological disorder categorized by a decrease
or absence of one or more of the globin chains synthesis. Beta‐thalassemia is caused by …

Thalassaemia

AT Taher, DJ Weatherall, MD Cappellini - The Lancet, 2018 - thelancet.com
Inherited haemoglobin disorders, including thalassaemia and sickle-cell disease, are the
most common monogenic diseases worldwide. Several clinical forms of α-thalassaemia and …

β-Thalassemia

R Origa - Genetics in medicine, 2017 - nature.com
Abstract β-Thalassemia is caused by reduced (β+) or absent (β 0) synthesis of the β-globin
chains of hemoglobin. Three clinical and hematological conditions of increasing severity are …

Clinical classification, screening and diagnosis for thalassemia

V Viprakasit, S Ekwattanakit - Hematology/Oncology Clinics, 2018 - hemonc.theclinics.com
Over the past decade, our knowledge of the clinical diagnosis and management of
thalassemia has progressed extensively. In recent years, the most critical change in clinical …

The role of iron repletion in adult iron deficiency anemia and other diseases

B Elstrott, L Khan, S Olson… - European journal of …, 2020 - Wiley Online Library
Iron deficiency anemia (IDA) is the most prevalent and treatable form of anemia worldwide.
The clinical management of patients with IDA requires a comprehensive understanding of …

Iron overload in human disease

RE Fleming, P Ponka - New England Journal of Medicine, 2012 - Mass Medical Soc
Iron Overload in Human Disease | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia

L Kautz, G Jung, X Du, V Gabayan… - Blood, The Journal …, 2015 - ashpublications.org
Inherited anemias with ineffective erythropoiesis, such as β-thalassemia, manifest
inappropriately low hepcidin production and consequent excessive absorption of dietary …

Non-transfusion-dependent thalassemias

KM Musallam, S Rivella, E Vichinsky… - …, 2013 - pmc.ncbi.nlm.nih.gov
Non-transfusion-dependent thalassemias include a variety of phenotypes that, unlike
patients with beta (β)-thalassemia major, do not require regular transfusion therapy for …

Thalassaemia

DR Higgs, JD Engel, G Stamatoyannopoulos - The lancet, 2012 - thelancet.com
Thalassaemia is one of the most common genetic diseases worldwide, with at least 60 000
severely affected individuals born every year. Individuals originating from tropical and …

[HTML][HTML] A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?

MD Cappellini, JB Porter, V Viprakasit, AT Taher - Blood reviews, 2018 - Elsevier
Beta-thalassaemia causes defective haemoglobin synthesis leading to ineffective
erythropoiesis, chronic haemolytic anaemia, and subsequent clinical complications. Blood …